Idelalisib plus rituximab improves progression-free survival in relapsed CLL
Image: PD 1. Idelalisib plus rituximab improved progression-free survival in patients with relapsing CLL compared to rituximab plus placebo. This ...
Tag: rituximab
2 Minute Medicine Rewind February 17 – February 23, 2014
Image: PD In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the ...
Rituximab not beneficial long-term in Sjorgen’s Syndrome
Image: PD 1. The results of this study suggest that rituximab (Rituxin) treatment is not associated with a significant improvement ...
2 Minute Medicine Rewind Jan 20 – Jan 26, 2014
Image: PD In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the ...
Rituximab linked with reduced chronic immune disease following stem cell transplantation
Image: PD AML 1. Rituximab use is linked with a reduction in chronic graft-vs-host disease following peripheral blood stem cell ...
Rituximab noninferior to conventional therapy in ANCA-associated vasculitis: RAVE Trial
Image: PD/Rituximab (Rituxan, MabThera) 1. At 18 months, patients with ANCA-associated vasculitis treated with one course of rituximab had similar ...
The RAVE trial: Rituximab for ANCA-associated vasculitis [Classics Series]
Image: PD 1. Rituximab is non-inferior to cyclophosphamide in inducing remission of severe ANCA-associated vasculitis. 2. There were no significant ...
2 Minute Medicine Rewind: May 20 – May 27
May 20 - 27, 2013 In this section, we will highlight the some of the high-impact studies, updates, and analyses ...
